GlaxoSmithKline (GSK)

Sector: Pharma and Biotech     Index: FTSE 100
-0.69%
-10.00p
1,442.50p
16:50 31/05/16

   Spread betting | CFDs | Stockbroking   Trade now with IG Sponsored by IG. Losses can exceed deposits

1,442.50p
16:50 31/05/16
DAILY VARIATION
-0.69%
-10.00p
VOLUME
4,591,993
REAL TIME BATS
1,442.50p
16:50 31/05/16
-0.69%
-10.00p
DATA
52 Week High
1,510.00p
52 Week Low
1,237.50p
Shares Issued
4,871.49m
Market Cap
£70,271.28m
RiskGrade
87
Beta
0.88
MENU

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 5.5% 5.6%
Div Cover 0.9 1.1
Op Mrgn 43.1% 23.8%
ROCE 272.9%
Latest F'cast
P/E 19.2 16.3
PEG -0.9 1.0
Pr/Revenue 3.0 2.8
Pr/Book 8.0
Latest F'cast
Revenue 4.0% 2.4%
PBT 254.6% n/a
EPS -20.6% -2.2%
DPS 0.0% 0.1%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2011-12-31 27,387.00 7,698.00 114.10p 12.9 0.1 112% 70.00p 4.8%
2012-12-31 26,431.00 6,600.00 111.40p 12.0 -5.1 -2% 74.00p 5.5%
2013-12-31 26,505.00 6,647.00 108.40p 14.9 -5.5 -3% 78.00p 4.8%
2014-12-31 23,006.00 2,968.00 95.40p 14.4 -1.2 -12% 80.00p 5.8%
2015-12-31 23,923.00 10,526.00 75.70p 18.1 -0.9 -21% 80.00p 5.8%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2016-12-31 25,706.68 6,110.87 87.65p 16.3 1.0 16% 81.74p 5.6%
2017-12-31 26,549.54 6,386.56 91.49p 15.8 3.6 4% 79.95p 5.5%

Regulatory News

slide to see more

Newspaper Links

No results found
No results found